Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  GW Pharmaceuticals plc       GB0030544687

GW PHARMACEUTICALS PLC

SummaryNewsRatingsCalendarCompany 
Business Summary
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.

Number of employees : 901 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Novel Therapeutics35.29227.5%395.90127.2% +1021.77%
Other0.1971.3%1.280.4% +547.1%
Sales per region
2019
USD (in Million)%
United States367.62118.1%
Europe21.076.8%
Other5.231.7%
United Kingdom3.251%
Managers and Directors
NameAgeSinceTitle
Justin D. Gover49-Chief Executive Officer & Executive Director
Geoffrey William Guy, Dr.661998Chairman
Christopher John Tovey552012Chief Operating Officer
Scott M. Giacobello502017CFO & Principal Accounting Officer
Volker Knappertz, Dr.552017Chief Medical Officer
James Julian Noble612007Deputy Chairman
Cabot Brown592013Independent Non-Executive Director
Catherine J. Mackey, Dr.642017Independent Non-Executive Director
Alicia Secor582017Independent Non-Executive Director
William Arthur Waldegrave742017Independent Non-Executive Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 374,169,836 370,428,138 99.0% 0 0.0% 99.0%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 3,732,712 12.0%
Capital Research & Management Co. (World Investors) 2,754,644 8.83%
Franklin Advisers, Inc. 2,223,859 7.13%
Janus Capital Management LLC 2,041,289 6.55%
Canada Pension Plan Investment Board 1,500,000 4.81%
Federated Global Investment Management Corp. 861,744 2.76%
Morgan Stanley Smith Barney LLC (Investment Management) 821,731 2.64%
Scopia Capital Management LP 749,538 2.40%
Consonance Capital Management LP 604,604 1.94%
Victory Capital Management, Inc. (Investment Management) 573,752 1.84%
Company contact information
GW Pharmaceuticals Plc
Sovereign House
Vision Park, Chivers Way
Histon
Cambridge, Cambridgeshire CB24 9BZ

Phone : +44.1223.266800
Fax : +44.1223.235667
Web : http://www.gwpharm.com
Sector Bio Therapeutic Drugs